Troubling for Public Health Institution to Depart from Established Norms to Support Drug of Questionable Efficacy with Unjustifiable Price Tag For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today reflecting on the recent U.S. Food and Drug Administration (FDA) approval of Alzheimer’s treatment […]
Campaign Calls for Promises Made to the American People to Lower Prescription Drug Prices to Become Promises Kept For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) launched new television and digital advertising Tuesday encouraging policymakers to hold brand name drug companies accountable. The ad blitz, […]
Time for the Administration and Congress to Convert Promises Made Into Promises Kept For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Friday on the release of President Biden’s Fiscal Year 2022 budget. “CSRxP commends President Biden for renewing his commitment to lowering prescription […]
Administration and Congress Must Work Together To Pass Solutions to Hold Big Pharma Accountable and Deliver Relief for American People For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Wednesday in reaction to President Biden’s comments calling for Congress to pass solutions to lower […]
Holding Big Pharma Accountable Remains Top Priority for American Voters For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Wednesday ahead of President Biden’s introduction of the “American Families Plan” in an address to Congress. “We thank the President for correctly recognizing the importance […]
Congress and the Administration Must Act on Solutions that Have Won Bipartisan Support to Deliver Relief for American Patients and Consumers For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on the reintroduction of the Elijah E. Cummings Lower Drug Costs Now Act […]
Lawmakers Pass Pair of Bills Aimed at Boosting Generic and Biosimilar Competition For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Thursday applauding the passage of the Ensuring Innovation Act and the Advancing Education on Biosimilars Act of 2021 in the U.S. House of […]
Campaign Will Highlight Impact of Out-of-Control Drug Prices, Especially in Areas like Oncology, and the Urgency to Hold Big Pharma Accountable For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) launched a campaign Tuesday encouraging policymakers to act on campaign promises to hold Big Pharma accountable […]
Government Report Finds No Relationship Between Drug Company R&D and Prescription Drug Prices For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday responding to a new report from the Congressional Budget Office (CBO) titled “Research and Development in the Pharmaceutical Industry,” which […]
Legislation Will Boost Transparency to Hold Big Pharma Accountable for Egregious Pricing Practices For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today applauding the reintroduction of The Fair Accountability and Innovative Research (FAIR) Drug Pricing Act in the U.S. Senate. “Greater list price […]